ELEVAR THERAPEUTICS
Live / Registered — Registered (as of 26 Nov 2024)
What this means for you
Registered since 26 Nov 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 26 Nov 2030: the §8 declaration of use).
Record
- Serial number
- 88985348
- Registration number
- 7579989
- Mark type
- Design + words
- Filed
- 16 Sept 2019
- Published for opposition
- 20 Apr 2021
- Registered
- 26 Nov 2024
- Next maintenance filing
- §8 declaration of use, due by 26 Nov 2030 (grace period to 26 May 2031)
- Attorney of record
- Cynthia Walden
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research; conducting clinical trials for others in the field of cancer therapeutics, distributed primarily to healthcare professionals; research and development in the field of cancer treatments
Owner
- Elevar Therapeutics, Inc., Salt Lake City, UT, US
- Elevar Therapeutics, Inc., Salt Lake City, UT, US
- Elevar Therapeutics, Inc., Salt Lake City, UT, US
Prosecution history
- 26 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
- 16 Feb 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 15 Feb 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Feb 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Dec 2023 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 22 Dec 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Dec 2023 — USE AMENDMENT FILED
- 22 Dec 2023 — DIVISIONAL PROCESSING COMPLETE
- 13 Dec 2023 — DIVISIONAL REQUEST RECEIVED
- 13 Dec 2023 — TEAS REQUEST TO DIVIDE RECEIVED
- 13 Dec 2023 — TEAS STATEMENT OF USE RECEIVED
- 13 Dec 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jun 2023 — SOU EXTENSION 4 GRANTED